Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator agent with $\beta$-adrenergic agonist activity.
## Primary Indications
* Peripheral vascular disease (e.g., arteriosclerosis obliterans, intermittent claudication).
* Cerebrovascular insufficiency.
* To prevent premature labor (off-label use, generally not recommended due to safety concerns and availability of more effective agents).
## Adult Dosing
* **Peripheral vascular disease/Cerebrovascular insufficiency:** 10-20 mg orally three to four times daily.
* **Premature labor (off-label):** 10 mg orally every 4 hours for up to 4 doses, then 20 mg every 4-6 hours. Due to significant risks, this indication is rarely used.
## Pediatric Dosing
There is no established pediatric dosing. Use is generally not recommended.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment. However, caution is advised in patients with significant comorbidities.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Use during the immediate postpartum period.
* Use in patients with congenital heart disease or those requiring cardiac medication.
* Use in patients who have had a recent myocardial infarction.
## Adverse Effects
* **Common:** Hypotension, dizziness, lightheadedness, weakness, nausea, vomiting, flushing, headache.
* **Less Common:** Palpitations, abdominal distress, drowsiness, nervousness.
## Key Drug Interactions
* **Antihypertensives:** May potentiate hypotensive effects.
* **Sympathomimetic agents:** May increase the risk of cardiovascular side effects.
## Monitoring
* Blood pressure.
* Heart rate.
* Symptoms of peripheral vascular disease or cerebrovascular insufficiency.
## Clinical Pearls
* Efficacy in peripheral vascular disease is controversial, and clinical benefit may be limited.
* Often administered with meals to minimize gastrointestinal upset.
* Avoid concurrent use with other sympathomimetic agents.
* Use in pregnancy for tocolysis is generally discouraged due to risks and lack of superior efficacy compared to other agents.
***
**Disclaimer:** This information is intended for clinical pharmacists and healthcare professionals. It is essential to consult the most current prescribing information and relevant literature for definitive guidance. Dosing and indications may vary based on local protocols and individual patient circumstances.
